FGF23 and Cause-Specific Mortality in Community-Living Individuals—The Health, Aging, and Body Composition Study

Academic Article

Abstract

  • Objectives: Fibroblast growth factor (FGF)-23 is a key regulator of mineral metabolism and has been linked with left ventricular hypertrophy in animal models. Most existing epidemiologic studies evaluated a C-terminal FGF23 assay which measures both the intact (active) hormone and inactive fragments. The relationship of intact FGF23 with cause-specific mortality is unknown. Design: Prospective analyses of data from Health, Aging, & Body Composition (HABC) study. Setting: Community-living adults aged 70 to 79 years with longitudinal follow up.
  • Digital Object Identifier (doi)

    Author List

  • Sharma S; Katz R; Dubin RF; Drew DA; Gutierrez OM; Shlipak MG; Sarnak MJ; Ix JH
  • Start Page

  • 711
  • End Page

  • 717
  • Volume

  • 69
  • Issue

  • 3